Renaissance Technologies’s Sonnet BioTherapeutics SONN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,469
| Closed | -$76K | – | 4047 |
|
|
2023
Q4 | $76K | Buy |
5,469
+3,088
| +130% | +$42.9K | ﹤0.01% | 3372 |
|
|
2023
Q3 | $55K | Buy |
2,381
+711
| +43% | +$16.4K | ﹤0.01% | 3386 |
|
|
2023
Q2 | $144K | Buy |
1,670
+1,578
| +1,715% | +$136K | ﹤0.01% | 3379 |
|
|
2023
Q1 | $6K | Buy |
+92
| New | +$6K | ﹤0.01% | 3908 |
|
|
2022
Q3 | – | Sell |
-32
| Closed | -$22K | – | 4375 |
|
|
2022
Q2 | $22K | Sell |
32
-699
| -96% | -$481K | ﹤0.01% | 4109 |
|
|
2022
Q1 | $677K | Buy |
731
+595
| +438% | +$551K | ﹤0.01% | 2986 |
|
|
2021
Q4 | $138K | Buy |
136
+89
| +189% | +$90.3K | ﹤0.01% | 3623 |
|
|
2021
Q3 | $70K | Buy |
+47
| New | +$70K | ﹤0.01% | 3359 |
|
|
2020
Q1 | – | Sell |
-1
| Closed | -$34K | – | 3758 |
|
|
2019
Q4 | $34K | Hold |
1
| – | – | ﹤0.01% | 3424 |
|
|
2019
Q3 | $49K | Hold |
1
| – | – | ﹤0.01% | 3329 |
|
|
2019
Q2 | $39K | Buy |
+1
| New | +$39K | ﹤0.01% | 3472 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3386 |
|